Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity-Reference-Cited by-同舟云学术

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

Published:2019-08-21 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Garrido Greta,Schrand Brett,Rabasa Ailem,Levay Agata,D’Eramo Francesca,Berezhnoy Alexey,Modi Shrey,Gefen Tal,Marijt Koen^ORCID,Doorduijn Elien,Dudeja Vikas,van Hall Thorbald^ORCID,Gilboa Eli

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-11728-2.pdf

Reference56 articles.

1. Schumacher, T. N. & Hacohen, N. Neoantigens encoded in the cancer genome. Curr. Opin. Immunol. 41, 98–103 (2016).

2. Yarchoan, M., Johnson, B. A. 3rd, Lutz, E. R., Laheru, D. A. & Jaffee, E. M. Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer 17, 209–222 (2017).

3. Lee, C. H., Yelensky, R., Jooss, K. & Chan, T. A. Update on tumor neoantigens and their utility: why it is good to be different. Trends Immunol. 39, 536–548 (2018).

4. Hu, Z., Ott, P. A. & Wu, C. J. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168–182 (2018).

5. McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463–1469 (2016).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyvalent Aptamer-Functionalized NIR-II Quantum Dots for Targeted Theranostics in High PD-L1-Expressing Tumors;ACS Applied Materials & Interfaces;2024-04-18

2. Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment;Molecules;2024-03-25

3. An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity;Cardiovascular Drugs and Therapy;2024-02-24

4. Vaccination against neoantigens induced in cross-priming cDC1 in vivo;Cancer Immunology, Immunotherapy;2024-01

5. Combination of irinotecan silicasome nanoparticles with radiation therapy sensitizes immunotherapy by modulating the activation of the cGAS/STING pathway for colorectal cancer;Materials Today Bio;2023-12